TMEM88 inhibits extracellular matrix expression in keloid fibroblasts - 14/11/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Keloid is characterized by hyper-proliferation of fibroblasts and excess extracellular matrix (ECM) deposition. Transmembrane protein 88 (TMEM88), belonging to the TMEM family, was involved in the regulation of tumorigenesis and fibrogenesis. However, the role of TMEM88 in keloid formation remains unclear. This study aimed to investigate the effects of TMEM88 on keloid-derived fibroblasts (KFs) proliferation and ECM expression, and explore the underlying mechanism. Our results demonstrated that TMEM88 was lowly expressed in human keloid tissues and TGF-β1-stimulated KFs. TMEM88 overexpression significantly inhibited the proliferation and migration of KFs, as well as suppressed ECM expression in TGF-β1-stimulated KFs. Furthermore, TMEM88 overexpression greatly inhibited the protein levels of β-catenin, cyclin D1 and c-myc in TGF-β1-stimulated KFs. In conclusion, our data indicate that TMEM88 inhibits the TGF-β1-stimulated cell proliferation, migration and ECM expression in KFs through the inactivation of Wnt/β-catenin signaling pathway. Therefore, TMEM88 may be a potential therapeutic target for treating keloids.
Le texte complet de cet article est disponible en PDF.Keywords : Keloid, TMEM88, TGF-β1, Extracellular matrix (ECM)
Plan
Vol 95
P. 1436-1440 - novembre 2017 Retour au numéro
Article précédent
- P38 MAP kinase is involved in oleuropein-induced apoptosis in A549 cells by a mitochondrial apoptotic cascade
- Shasha Cao, Xixi Zhu, Linfang Du
- Phytochemical characterization and bioactivity of Lycium europaeum: A focus on antioxidant, antinociceptive, hepatoprotective and nephroprotective effects
- Ilhem Rjeibi, Anouar Feriani, Anouar Ben Saad, Sana Ncib, Jazia Sdayria, Issam Saidi, Sami Souid, Najla Hfaiedh, Mohamed Salah Allagui
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?